1239319-94-8 Usage
Uses
Used in Pharmaceutical Industry:
6-Boc-2-aMino-6-aza-spiro[3.4]octane-6-carboxylate is used as a synthesis reagent for the development of new pharmaceutical compounds. Its ability to react with various other chemicals allows for the creation of a wide range of drug candidates with potential therapeutic applications.
Used in Research and Development:
As a pharmaceutical intermediate, 6-Boc-2-aMino-6-aza-spiro[3.4]octane-6-carboxylate plays a crucial role in the research and development of new drugs. It serves as a building block for the synthesis of more complex molecules, which can be further studied for their potential medicinal properties.
Used in Biological Studies:
6-Boc-2-aMino-6-aza-spiro[3.4]octane-6-carboxylate is also used as a research chemical in biological studies. Its unique structure allows researchers to investigate its interactions with various biological targets, such as proteins and enzymes, which can provide valuable insights into the development of new therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 1239319-94-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,3,1 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1239319-94:
(9*1)+(8*2)+(7*3)+(6*9)+(5*3)+(4*1)+(3*9)+(2*9)+(1*4)=168
168 % 10 = 8
So 1239319-94-8 is a valid CAS Registry Number.
1239319-94-8Relevant articles and documents
DERIVATIVES OF AZASPIRANYL-ALKYLCARBAMATES OF 5-MEMBER HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
-
, (2012/01/13)
The invention relates to a compound of the general formula (I) in which R2 is a hydrogen or fluorine atom or a hydroxyl, cyano, trifluoromethyl, C1-6-alkyl, C1-6-alkoxy, NR8R9 group; m, n, o and p are independently an integer equal to 0, 1, 2 or 3; A is a covalent bond or a C1-8-alkylene group; R1 is an optionally substituted aryl or heteroaryl group; R3 is a hydrogen or fluorine atom or a C1-6-alkyl group or a trifluoromethyl group; R4 is an optionally substituted 5-member heterocyclic compound; the compound being in the form of a base or acid addition salt. The invention also relates to the therapeutic use thereof.